| Current Price | $8.00 | Mkt Cap | $649.0M |
|---|---|---|---|
| Open | $7.85 | P/E Ratio | -2.69 |
| Prev. Close | $8.00 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $7.71 - $8.05 | Volume | 1,118,679 |
| 52-Wk Range | $6.33 - $14.23 | Avg. Daily Vol. | 1,403,995 |
| Current Price | $8.00 | Mkt Cap | $649.0M |
|---|---|---|---|
| Open | $7.85 | P/E Ratio | -2.69 |
| Prev. Close | $8.00 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $7.71 - $8.05 | Volume | 1,118,679 |
| 52-Wk Range | $6.33 - $14.23 | Avg. Daily Vol. | 1,403,995 |
The best Bull and Bear pitches based on recency and number of recommendations.
Gene editing will be a huge growth industry in the future of health care
Not ready to take off yet, will out perform in long run, but not sure when that long run starts. Not this year.
Read the most recent pitches from players about EDIT.
Recs
mrbill6
(48.96)
Submitted: 6/24/2023 1:15:48 AM :
Start Price:
$8.06
NASDAQ:EDIT Score:
-0.46
Fool.com 5 Stocks to Buy Now
Recs
quist1
(< 20)
Submitted: 9/29/2022 2:02:12 PM :
Start Price:
$12.16
NASDAQ:EDIT Score:
+53.83
Good for tax harvesting, revisit next year, good stock with solid technology. Perhaps options, no rush, this market to risky, hold onto the proven ones for now you can always revisit these.
Recs
TMFbonefish
(30.01)
Submitted: 4/20/2022 5:05:28 PM :
Start Price:
$15.70
NASDAQ:EDIT Score:
+45.22
So many red flags. Turnover at the top, questionable results, and other Crispr biotechs moving faster in the lab and through the FDA.
Find the members with the highest scoring picks in EDIT.
Dobby62 (55.11) Score: +242.71
The Score Leader is the player with the highest score across all their picks in EDIT.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| SeriousK | 28.07 | 3/9/2016 |
|
5Y | $42.70 | -81.26% | +116.39% | +197.65 | 0 Comment | |
| TimeToBuy | 93.10 | 3/10/2016 |
|
5Y | $32.50 | -75.38% | +115.74% | +191.12 | 0 Comment | |
| nobody2013 | < 20 | 3/10/2016 |
|
NS | $26.79 | -70.14% | +117.58% | +187.72 | 1 Comment | |
| chushogi | 60.24 | 1/9/2017 |
|
5Y | $18.05 | -55.68% | +90.12% | +145.79 | 0 Comment | |
| btechrisk11 | < 20 | 4/16/2018 |
|
3Y | $34.93 | -77.10% | +61.57% | +138.67 | 1 Comment | |
| LastPlaceLenny | 29.14 | 3/15/2019 |
|
1Y | $24.03 | -66.71% | +53.77% | +120.48 | 1 Comment | |
| hayrettin | 72.46 | 1/18/2022 |
|
5Y | $20.59 | -61.14% | -5.79% | +55.34 | 0 Comment | |
| quist1 | < 20 | 9/29/2022 |
|
1Y | $12.16 | -34.21% | +19.61% | +53.83 | 1 Comment | |
| TMFbonefish | 30.01 | 4/21/2022 |
|
5Y | $15.70 | -49.04% | -3.82% | +45.22 | 1 Comment | |
| mrbill6 | 48.96 | 6/26/2023 |
|
5Y | $8.06 | -0.74% | -0.28% | -0.46 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
